Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Plasma cell 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 20Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Sarcoma 4Neoplasms 4Urinary Bladder Neoplasms 3Ovarian Neoplasms 3Carcinoma, Merkel Cell 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Skin Neoplasms 2Neoplasm Metastasis 2Lymphoma, T-Cell, Cutaneous 2Lung Neoplasms 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Squamous Cell 1Neoplasms, Plasma Cell 1Mesothelioma 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1

Interventions

Gemcitabine 2Docetaxel 2tanespimycin 1resiquimod 1poly ICLC 1durvalumab 1capivasertib 1Thalidomide 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiosurgery 1Quality of Life 1Pentetic Acid 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Nutritional Support 1Molecular Diagnostic Techniques 1Minocycline 1Immunotherapy 1Immunologic Techniques 1Immunoglobulin G 1Imatinib Mesylate 1IPI-926 1Heparin 1Filgrastim 1Fentanyl 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × poly ICLC × Dermatologic × Clear all
NCT00948961 2016-06-27

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Celldex Therapeutics

Phase 1/2 Completed
70 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicPlasma cellSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡